We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Manage idiopathic hypersomnia with a combination of non-pharmacological and pharmacological treatments.
- Authors
Lee, Arnold
- Abstract
Idiopathic hypersomnia (IH) is a rare sleeping disorder that is difficult to diagnose, and little is known about its pathophysiology. A defining symptom of IH is excessive daytime sleepiness, which can manifest as narcolepsy-like episodes or as continuous sleepiness. Other symptoms of IH includes sleep inertia and cognitive impairment. Currently, calcium, magnesium, potassium and sodium oxybates is the only FDA approved pharmacological treatment option in the management of IH. Off-label treatment options are recommended by guidelines, with many also being used for the management of narcolepsy.
- Subjects
COGNITION disorders treatment; THERAPEUTIC use of magnesium; DRUG approval; SOCIAL support; POTASSIUM; HYPERSOMNIA; UNITED States. Food &; Drug Administration; NARCOLEPSY; GAMMA-hydroxybutyrate; MENTAL depression; HEALTH behavior; CALCIUM; ANXIETY; RARE diseases; DROWSINESS; OFF-label use (Drugs); HEALTH self-care
- Publication
Drugs & Therapy Perspectives, 2023, Vol 39, Issue 11, p378
- ISSN
1172-0360
- Publication type
Article
- DOI
10.1007/s40267-023-01028-7